Kewaunee Scientific Corporation
KEQU · NASDAQ
10/31/2025 | 7/31/2025 | 4/30/2025 | 1/31/2025 | |
|---|---|---|---|---|
| Revenue | $70 | $71 | $77 | $67 |
| % Growth | -1.4% | -7.8% | 14.9% | – |
| Cost of Goods Sold | $50 | $50 | $53 | $49 |
| Gross Profit | $20 | $21 | $24 | $18 |
| % Margin | 28.1% | 29.4% | 31.2% | 27.4% |
| R&D Expenses | $0 | $0 | $1 | $0 |
| G&A Expenses | $0 | $0 | $15 | $0 |
| SG&A Expenses | $0 | $0 | $16 | $16 |
| Sales & Mktg Exp. | $0 | $0 | $1 | $0 |
| Other Operating Expenses | $16 | $16 | -$1 | $0 |
| Operating Expenses | $16 | $16 | $16 | $16 |
| Operating Income | $4 | $5 | $9 | $2 |
| % Margin | 5.9% | 6.8% | 11% | 3.3% |
| Other Income/Exp. Net | -$1 | -$1 | -$1 | -$1 |
| Pre-Tax Income | $3 | $4 | $7 | $1 |
| Tax Expense | $1 | $1 | $2 | -$0 |
| Net Income | $2 | $3 | $5 | $1 |
| % Margin | 3.5% | 4.3% | 6.3% | 2% |
| EPS | 0.85 | 1.08 | 1.7 | 0.47 |
| % Growth | -21.3% | -36.5% | 261.7% | – |
| EPS Diluted | 0.82 | 1.04 | 1.63 | 0.45 |
| Weighted Avg Shares Out | 3 | 3 | 3 | 3 |
| Weighted Avg Shares Out Dil | 3 | 3 | 3 | 3 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $1 | $1 | $1 |
| Depreciation & Amortization | $2 | $2 | $2 | $2 |
| EBITDA | $6 | $7 | $10 | $4 |
| % Margin | 8.7% | 9.2% | 12.8% | 5.9% |